Senator Angus King says to be treated for prostate cancer

Published 06/22/2015, 01:52 PM
Senator Angus King says to be treated for prostate cancer

WASHINGTON (Reuters) - U.S. Senator Angus King of Maine said on Monday that he intends to undergo surgery on Friday for treatment of prostate cancer, but he hopes to return to work soon after the Senate's July recess.

King, one of only two Independent senators, said his doctors detected the cancer during an annual check-up in April. He said he expects to make a full recovery.

"And no, this does not my affect my intention to run for re-election, except my poor little prostate won't be along for the ride," King said in a press release.

This is the second time that King has been diagnosed with cancer. During a routine screening 40 years ago, he said doctors caught an aggressive form of skin cancer.

According to the American Cancer Society, about one in seven men will get prostate cancer during their lifetime.

The 71-year-old King, the junior senator from Maine, was sworn in January 2013. He served as the governor of Maine for two terms, from 1995 to 2003.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.